Global and Region Oncology Injection Drug Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Oncology Injection Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Oncology Injection Drugmarket, defines the market attractiveness level of Oncology Injection Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Oncology Injection Drug industry, describes the types of Oncology Injection Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Oncology Injection Drug market and the development prospects and opportunities of Oncology Injection Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Oncology Injection Drug market in Chapter 13.

    By Player:

    • Celgene

    • Praecis Pharmaceuticals

    • Taj Oncology

    • Pharmascience

    • Ferring Pharmaceuticals

    • Millennium Pharmaceuticals

    • SG Biopharm

    • Merrimack

    • AdvaCare

    • CordenPharma

    • Allos Therapeutics

    • Alza

    • Genzyme

    • Eli Lilly

    • Debiopharm

    By Type:

    • Organs

    • Central Nervous System

    • Circulatory/Musculoskeletal System

    By End-User:

    • Lymphoma

    • Myeloma

    • Prostate Cancer

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Oncology Injection Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Oncology Injection Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Oncology Injection Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Oncology Injection Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Oncology Injection Drug Market Analysis and Outlook to 2022

    • 7.1 Global Oncology Injection Drug Consumption (2017-2022)

    • 7.2 United States Oncology Injection Drug Consumption (2017-2022)

    • 7.3 Europe Oncology Injection Drug Consumption (2017-2022)

    • 7.4 China Oncology Injection Drug Consumption (2017-2022)

    • 7.5 Japan Oncology Injection Drug Consumption (2017-2022)

    • 7.6 India Oncology Injection Drug Consumption (2017-2022)

    • 7.7 South Korea Oncology Injection Drug Consumption (2017-2022)

    8 Region and Country-wise Oncology Injection Drug Market Analysis and Outlook to 2028

    • 8.1 Global Oncology Injection Drug Consumption Forecast (2022-2028)

    • 8.2 United States Oncology Injection Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Oncology Injection Drug Consumption Forecast (2022-2028)

    • 8.4 China Oncology Injection Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Oncology Injection Drug Consumption Forecast (2022-2028)

    • 8.6 India Oncology Injection Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Oncology Injection Drug Consumption Forecast (2022-2028)

    9 Global Oncology Injection Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Oncology Injection Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Organs Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Central Nervous System Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Circulatory/Musculoskeletal System Consumption and Growth Rate (2017-2022)

    • 9.2 Global Oncology Injection Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Lymphoma Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Myeloma Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    10 Global Oncology Injection Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Oncology Injection Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Organs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Central Nervous System Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Circulatory/Musculoskeletal System Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Oncology Injection Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Myeloma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    11 Global Oncology Injection Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Oncology Injection Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Oncology Injection Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Oncology Injection Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Oncology Injection Drug Market Competitive Analysis

    • 14.1 Celgene

      • 14.1.1 Celgene Company Details

      • 14.1.2 Celgene Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Celgene Oncology Injection Drug Product and Service

    • 14.2 Praecis Pharmaceuticals

      • 14.2.1 Praecis Pharmaceuticals Company Details

      • 14.2.2 Praecis Pharmaceuticals Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Praecis Pharmaceuticals Oncology Injection Drug Product and Service

    • 14.3 Taj Oncology

      • 14.3.1 Taj Oncology Company Details

      • 14.3.2 Taj Oncology Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Taj Oncology Oncology Injection Drug Product and Service

    • 14.4 Pharmascience

      • 14.4.1 Pharmascience Company Details

      • 14.4.2 Pharmascience Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Pharmascience Oncology Injection Drug Product and Service

    • 14.5 Ferring Pharmaceuticals

      • 14.5.1 Ferring Pharmaceuticals Company Details

      • 14.5.2 Ferring Pharmaceuticals Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Ferring Pharmaceuticals Oncology Injection Drug Product and Service

    • 14.6 Millennium Pharmaceuticals

      • 14.6.1 Millennium Pharmaceuticals Company Details

      • 14.6.2 Millennium Pharmaceuticals Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Millennium Pharmaceuticals Oncology Injection Drug Product and Service

    • 14.7 SG Biopharm

      • 14.7.1 SG Biopharm Company Details

      • 14.7.2 SG Biopharm Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 SG Biopharm Oncology Injection Drug Product and Service

    • 14.8 Merrimack

      • 14.8.1 Merrimack Company Details

      • 14.8.2 Merrimack Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Merrimack Oncology Injection Drug Product and Service

    • 14.9 AdvaCare

      • 14.9.1 AdvaCare Company Details

      • 14.9.2 AdvaCare Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 AdvaCare Oncology Injection Drug Product and Service

    • 14.10 CordenPharma

      • 14.10.1 CordenPharma Company Details

      • 14.10.2 CordenPharma Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 CordenPharma Oncology Injection Drug Product and Service

    • 14.11 Allos Therapeutics

      • 14.11.1 Allos Therapeutics Company Details

      • 14.11.2 Allos Therapeutics Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Allos Therapeutics Oncology Injection Drug Product and Service

    • 14.12 Alza

      • 14.12.1 Alza Company Details

      • 14.12.2 Alza Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Alza Oncology Injection Drug Product and Service

    • 14.13 Genzyme

      • 14.13.1 Genzyme Company Details

      • 14.13.2 Genzyme Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Genzyme Oncology Injection Drug Product and Service

    • 14.14 Eli Lilly

      • 14.14.1 Eli Lilly Company Details

      • 14.14.2 Eli Lilly Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Eli Lilly Oncology Injection Drug Product and Service

    • 14.15 Debiopharm

      • 14.15.1 Debiopharm Company Details

      • 14.15.2 Debiopharm Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Debiopharm Oncology Injection Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Oncology Injection Drug

    • Figure Oncology Injection Drug Picture

    • Table Global Oncology Injection Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Oncology Injection Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Oncology Injection Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Oncology Injection Drug Consumption by Country (2017-2022)

    • Figure United States Oncology Injection Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Oncology Injection Drug Consumption and Growth Rate (2017-2022)

    • Figure China Oncology Injection Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Oncology Injection Drug Consumption and Growth Rate (2017-2022)

    • Figure India Oncology Injection Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Oncology Injection Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Injection Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Oncology Injection Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Oncology Injection Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Oncology Injection Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Oncology Injection Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Oncology Injection Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Oncology Injection Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Organs Consumption and Growth Rate (2017-2022)

    • Figure Global Central Nervous System Consumption and Growth Rate (2017-2022)

    • Figure Global Circulatory/Musculoskeletal System Consumption and Growth Rate (2017-2022)

    • Figure Global Lymphoma Consumption and Growth Rate (2017-2022)

    • Figure Global Myeloma Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Organs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Central Nervous System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Circulatory/Musculoskeletal System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Myeloma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Oncology Injection Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Oncology Injection Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Celgene (Foundation Year, Company Profile and etc.)

    • Table Celgene Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Oncology Injection Drug Product and Service

    • Table Praecis Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Praecis Pharmaceuticals Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Praecis Pharmaceuticals Oncology Injection Drug Product and Service

    • Table Taj Oncology (Foundation Year, Company Profile and etc.)

    • Table Taj Oncology Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Taj Oncology Oncology Injection Drug Product and Service

    • Table Pharmascience (Foundation Year, Company Profile and etc.)

    • Table Pharmascience Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pharmascience Oncology Injection Drug Product and Service

    • Table Ferring Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Ferring Pharmaceuticals Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ferring Pharmaceuticals Oncology Injection Drug Product and Service

    • Table Millennium Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Millennium Pharmaceuticals Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Millennium Pharmaceuticals Oncology Injection Drug Product and Service

    • Table SG Biopharm (Foundation Year, Company Profile and etc.)

    • Table SG Biopharm Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table SG Biopharm Oncology Injection Drug Product and Service

    • Table Merrimack (Foundation Year, Company Profile and etc.)

    • Table Merrimack Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merrimack Oncology Injection Drug Product and Service

    • Table AdvaCare (Foundation Year, Company Profile and etc.)

    • Table AdvaCare Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table AdvaCare Oncology Injection Drug Product and Service

    • Table CordenPharma (Foundation Year, Company Profile and etc.)

    • Table CordenPharma Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table CordenPharma Oncology Injection Drug Product and Service

    • Table Allos Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Allos Therapeutics Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allos Therapeutics Oncology Injection Drug Product and Service

    • Table Alza (Foundation Year, Company Profile and etc.)

    • Table Alza Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alza Oncology Injection Drug Product and Service

    • Table Genzyme (Foundation Year, Company Profile and etc.)

    • Table Genzyme Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genzyme Oncology Injection Drug Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Oncology Injection Drug Product and Service

    • Table Debiopharm (Foundation Year, Company Profile and etc.)

    • Table Debiopharm Oncology Injection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Debiopharm Oncology Injection Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.